CoChat

Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice

Open access
Zhu, Tao, Wu, Xiao-ling, Zhang, Wei, Xiao, Min · 2015 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.

Abstract

Asthma is a common chronic pulmonary inflammatory disease, featured with mucus hyper-secretion in the airway. Recent studies found that glucagon like peptide-1 (GLP-1) analogs, including liraglutide and exenatide, possessed a potent anti-inflammatory property through a protein kinase A (PKA)-dependent signaling pathway. Therefore, the aim of current study was to investigate the value of GLP-1 analog therapy liraglutide in airway inflammation and mucus secretion in a murine model of ovalbumin (OVA)-induced asthma, and its underlying molecular mechanism. In our study, BALB/c mice were sensitized and challenged by OVA to induce chronic asthma. Pathological alterations, the number of cells and the content of inflammatory mediators in bronchoalveolar lavage fluid (BALF), and mucus secretion were observed and measured. In addition, the mRNA and protein expression of E-selectin and MUC5AC were analyzed by qPCR and Western blotting. Then, the phosphorylation of PKA and nuclear factor-κB (NF-κB) p65 were also measured by Western blotting. Further, NF-κB p65 DNA binding activity was detected by ELISA. OVA-induced airway inflammation, airway mucus hyper-secretion, the up-regulation of E-selectin and MUC5AC were remarkably inhibited by GLP-1 in mice (all p < 0.01). Then, we also found that OVA-reduced phosphorylation of PKA, and OVA-enhanced NF-κB p65 activation and NF-κB p65 DNA binding activity were markedly improved by GLP-1 (all p < 0.01). Furthermore, our data also figured out that these effects of GLP-1 were largely abrogated by the PKA inhibitor H-89 (all p < 0.01). Taken together, our results suggest that OVA-induced asthma were potently ameliorated by GLP-1 possibly through a PKA-dependent inactivation of NF-κB in mice, indicating that GLP-1 analogs may be considered an effective and safe drug for the potential treatment of asthma in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms160920195

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 GLP-1 improves pulmonary pathological alterations in OVA-induced chronic asthma. After 81 days of OVA sensitization and challenge, mice were sacrificed and their right lower lungs were fixed. Then, tissue sections were stained with hematoxylin and eosin (H&E). The Figure demonstrates a representative view (×200) from each group. (Inflammatory cells (arrows); Goblet cells (open arrows); Airway basement membrane (triangles)) Scale bar = 100 μm.
Figure 1 GLP-1 improves pulmonary pathological alterations in OVA-induced chronic asthma. After 81 days of OVA sensitization and challenge, mice were sacrificed and their right lower lungs were fixed. Then, tissue sections were stained with hematoxylin and eosin (H&E). The Figure demonstrates a representative view (×200) from each group. (Inflammatory cells (arrows); Goblet cells (open arrows); Airway basement membrane (triangles)) Scale bar = 100 μm.CC BY · PubMed Central
Figure 2 GLP-1 reduces cell counts and inflammatory mediators in BALF in OVA-induced chronic asthma. (A) Cells in BALF were collected and cytospin preparations were made. Total cells, neutrophils, macrophages, eosinophils, and lymphocytes in BALF were evaluated; (B) TNF-α, IL-4, IL-5, and IL-13 in BALF were detected by ELISA. Each bar represents the mean ± SD of 10 mice. * p < 0.05 compared with control. # p < 0.05 compared with OVA. † p < 0.05 compared with OVA + GLP-1 + H-89.
Figure 2 GLP-1 reduces cell counts and inflammatory mediators in BALF in OVA-induced chronic asthma. (A) Cells in BALF were collected and cytospin preparations were made. Total cells, neutrophils, macrophages, eosinophils, and lymphocytes in BALF were evaluated; (B) TNF-α, IL-4, IL-5, and IL-13 in BALF were detected by ELISA. Each bar represents the mean ± SD of 10 mice. * p < 0.05 compared with control. # p < 0.05 compared with OVA. † p < 0.05 compared with OVA + GLP-1 + H-89.CC BY · PubMed Central
Figure 3 GLP-1 down-regulates E-selectin in the lung tissues in OVA-induced chronic asthma. (A) qPCR was used to measure E-selectin mRNA expression in lung; (B) Western blotting was performed to measure E-selectin protein expression in lung. Each bar represents the mean ± SD of 10 mice. * p < 0.05 compared with control. # p < 0.05 compared with OVA. † p < 0.05 compared with OVA + GLP-1 + H-89.
Figure 3 GLP-1 down-regulates E-selectin in the lung tissues in OVA-induced chronic asthma. (A) qPCR was used to measure E-selectin mRNA expression in lung; (B) Western blotting was performed to measure E-selectin protein expression in lung. Each bar represents the mean ± SD of 10 mice. * p < 0.05 compared with control. # p < 0.05 compared with OVA. † p < 0.05 compared with OVA + GLP-1 + H-89.CC BY · PubMed Central
Figure 4 GLP-1 inhibits airway mucus secretion in OVA-induced chronic asthma. (A) After 81 days of OVA sensitization and challenge, mice were sacrificed and their right lower lungs were fixed. Then, tissue sections were stained with periodic acid-Schiff (PAS) staining. The Figure demonstrates a representative view (×200) from each group; (Mucus (open arrows)); Scale bar = 100μm; (B) the mucus index was calculated as the percentage of the mucus-positive area of the whole bronchial epithelium; (C) qPCR was used to measure MUC5AC mRNA expression in lung; (D) Western blotting was performed to measure MUC5AC protein expression in lung. Each bar represents the mean ± SD of 10 mice. * p < 0.05 compared with Control. # p < 0.05 compared with OVA. † p < 0.05 compared with OVA + GLP-1 + H-89. Scale bar = 100 μm.
Figure 4 GLP-1 inhibits airway mucus secretion in OVA-induced chronic asthma. (A) After 81 days of OVA sensitization and challenge, mice were sacrificed and their right lower lungs were fixed. Then, tissue sections were stained with periodic acid-Schiff (PAS) staining. The Figure demonstrates a representative view (×200) from each group; (Mucus (open arrows)); Scale bar = 100μm; (B) the mucus index was calculated as the percentage of the mucus-positive area of the whole bronchial epithelium; (C) qPCR was used to measure MUC5AC mRNA expression in lung; (D) Western blotting was performed to measure MUC5AC protein expression in lung. Each bar represents the mean ± SD of 10 mice. * p < 0.05 compared with Control. # p < 0.05 compared with OVA. † p < 0.05 compared with OVA + GLP-1 + H-89. Scale bar = 100 μm.CC BY · PubMed Central
Figure 5 GLP-1 promotes the phosphorylation of PKA in lung in OVA-induced chronic asthma. Western blotting was performed to evaluate the phosphorylation of PKA in the lung tissues. Each bar represents the mean ± SD of 10 mice. * p < 0.05 compared with Control. # p <0.05 compared with OVA. † p < 0.05 compared with OVA + GLP-1 + H-89. ‡ p < 0.05 compared with OVA + GLP-1.
Figure 5 GLP-1 promotes the phosphorylation of PKA in lung in OVA-induced chronic asthma. Western blotting was performed to evaluate the phosphorylation of PKA in the lung tissues. Each bar represents the mean ± SD of 10 mice. * p < 0.05 compared with Control. # p <0.05 compared with OVA. † p < 0.05 compared with OVA + GLP-1 + H-89. ‡ p < 0.05 compared with OVA + GLP-1.CC BY · PubMed Central
Figure 6 GLP-1 blocks OVA-induced NF-κB activation and DNA binding activity in lung. (A) Western blotting was used to analyze the phosphorylation of NF-κB p65 in lung; (B) DNA binding activity of NF-κB p65 was measured by a TransAM™ p65 transcription factor ELISA kit. Each bar represents the mean ± SD of 10 mice. * p < 0.05 compared with Control. # p < 0.05 compared with OVA. † p < 0.05 compared with OVA + GLP-1 + H-89.
Figure 6 GLP-1 blocks OVA-induced NF-κB activation and DNA binding activity in lung. (A) Western blotting was used to analyze the phosphorylation of NF-κB p65 in lung; (B) DNA binding activity of NF-κB p65 was measured by a TransAM™ p65 transcription factor ELISA kit. Each bar represents the mean ± SD of 10 mice. * p < 0.05 compared with Control. # p < 0.05 compared with OVA. † p < 0.05 compared with OVA + GLP-1 + H-89.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 107

Metadata

Authors
Zhu, T., Wu, X.-L., Zhang, W., & Xiao, M.
Affiliations
  • West China Hospital of Sichuan University (CN)
  • Department of Respiratory Medicine, and Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, West China Hospital of Sichuan University, Chengdu 610041, China
  • First Affiliated Hospital of Chengdu Medical College (CN)
Corresponding author
Xiao, Min
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2015-08-26
Volume
16
Issue
9
Pages
20195-20211
ISSN
1422-0067 (ISSN-L)
OpenAlex
W1915288020
Cited by
106
References
58
Citations by year
2026: 10 · 2025: 12 · 2024: 10 · 2023: 10 · 2022: 13 · 2021: 13 · 2020: 11 · 2019: 9 · 2018: 9 · 2017: 5 · 2016: 4
FWCI
4.42
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Applying Fundamental Research Foundation of Sichuan Province of China (2013JY0032)
  • China Postdoctoral Science Foundation (2014M552369)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
glucagon-like peptide-1, liraglutide, asthma, airway inflammation, mucus hypersecretion, ovalbumin-induced asthma, protein kinase A, NF-κB signaling, NF-κB p65, E-selectin, MUC5AC, H89, anti-inflammatory therapy
MeSH terms
Animals, Asthma, Bronchoalveolar Lavage Fluid, Disease Models, Animal, Leukocyte Count, Leukocytes, Mucus, Ovalbumin, Signal Transduction, Cytokines, NF-kappa B, Cyclic AMP-Dependent Protein Kinases, Inflammation Mediators, E-Selectin, Mice, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.